We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$12.9B
AUM Growth
+$12.9B
Cap. Flow
+$2.44B
Cap. Flow %
18.95%
Top 10 Hldgs %
13.49%
Holding
489
New
192
Increased
92
Reduced
78
Closed
35

Top Sells

Rank Stock Value
1
HQY icon
HealthEquity
HQY
+$34.8M
2
RCL icon
Royal Caribbean
RCL
+$33.2M
3
OMCL icon
Omnicell
OMCL
+$29.2M
4
TYL icon
Tyler Technologies
TYL
+$29.1M
5
CGNX icon
Cognex
CGNX
+$28.3M

Sector Composition

Rank Sector Weight
1 Healthcare 18.54%
2 Technology 17.46%
3 Industrials 16.92%
4 Consumer Discretionary 15.93%
5 Financials 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNV
26
DELISTED
Synovus
SNV
$83.3M 0.65%
1,706,098
-546,675
-24% -$27.5M
PVH icon
27
PVH
PVH
$3.97B
$80.2M 0.62%
52,975
+32,650
+161% +$4.76M
RP
28
DELISTED
RealPage, Inc.
RP
$78.3M 0.61%
1,568,452
UEIC icon
29
Universal Electronics
UEIC
$58.1M
$75.2M 0.58%
1,502,697
ALGN icon
30
Align Technology
ALGN
$12.8B
$74.1M 0.58%
345,888
+62,820
+22% +$16.1M
CGNX icon
31
Cognex
CGNX
$9.56B
$73.8M 0.57%
1,511,418
-478,070
-24% -$28.3M
FANG icon
32
Diamondback Energy
FANG
$56.1B
$73.8M 0.57%
601,875
+29,311
+5% +$3.69M
PRAH
33
DELISTED
PRA Health Sciences, Inc.
PRAH
$71.8M 0.56%
884,003
NKTR icon
34
Nektar Therapeutics
NKTR
$2.3B
$71.2M 0.55%
48,028
PFPT
35
DELISTED
Proofpoint, Inc.
PFPT
$71.1M 0.55%
632,558
OMCL icon
36
Omnicell
OMCL
$1.97B
$70.3M 0.55%
162,000
-634,115
-80% -$29.2M
JBTM
37
JBT Marel
JBTM
$7.24B
$68.6M 0.53%
634,254
+10,664
+2% +$1.22M
SIRI icon
38
SiriusXM
SIRI
$10.7B
$68.4M 0.53%
1,119,649
+122,586
+12% +$7.36M
GTLS
39
DELISTED
Chart Industries
GTLS
$68.3M 0.53%
1,189,196
+70,707
+6% +$3.8M
PGR icon
40
Progressive
PGR
$129B
$67.8M 0.53%
1,132,996
+246,938
+28% +$14.1M
TREX icon
41
Trex
TREX
$4.38B
$67.5M 0.53%
2,547,636
HXL icon
42
Hexcel
HXL
$7.89B
$67M 0.52%
1,056,896
-423,556
-29% -$27.9M
SAGE
43
DELISTED
Sage Therapeutics
SAGE
$65.8M 0.51%
451,097
OLLI icon
44
Ollie's Bargain Outlet
OLLI
$4.29B
$64.8M 0.5%
1,095,415
TDOC icon
45
Teladoc Health
TDOC
$1.66B
$64M 0.5%
1,663,489
BLDR icon
46
Builders FirstSource
BLDR
$7.42B
$63.6M 0.49%
3,393,907
+63,950
+2% +$1.35M
LSTR icon
47
Landstar System
LSTR
$6.15B
$62.4M 0.49%
583,979
PEGA icon
48
Pegasystems
PEGA
$5.07B
$61.8M 0.48%
2,069,802
GWRE icon
49
Guidewire Software
GWRE
$13.9B
$60.7M 0.47%
770,979
GDOT icon
50
Green Dot
GDOT
$757M
$59.5M 0.46%
958,585

Similar funds

Carillon Tower Advisers's Q1 2018 Portfolio in Review

As of Q1 2018, Carillon Tower Advisers held 489 positions worth $12.9B, up 136,756% from $9.4M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Carillon Tower Advisers deployed $2.44B of net new capital in Q1 2018, opening 192 new positions and adding to 92 existing holdings. Its largest new stake was Voya Financial: 871,250 shares worth $4.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was HealthEquity, an estimated $34.8M trimmed.

  • Carillon Tower Advisers's largest Q1 2018 buy was Voya Financial: 871,250 shares worth $4.4M.
  • Carillon Tower Advisers added most to DXC Technology in Q1 2018, an estimated $101M increase.
  • Carillon Tower Advisers's biggest Q1 2018 reduction was HealthEquity, cutting an estimated $34.8M.
  • Carillon Tower Advisers fully exited Prestige Consumer Healthcare in Q1 2018, selling an estimated $404K.
  • Carillon Tower Advisers's ten largest holdings make up 13% of its $12.9B portfolio in Q1 2018.
  • Carillon Tower Advisers opened 192 new positions and closed 35 in Q1 2018.
  • Carillon Tower Advisers's portfolio value rose 136,756% quarter-over-quarter to $12.9B.

Based on Carillon Tower Advisers's 13F filing for Q1 2018, filed 14 May 2018.